John C. Castle - 23 Jun 2021 Form 3 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Role
Chief Data Scientist
Signature
/s/ Ajim Tamboli, Attorney-in-Fact
Issuer symbol
GLUE
Transactions as of
23 Jun 2021
Net transactions value
$0
Form type
3
Filing time
23 Jun 2021, 20:44:15 UTC
Next filing
02 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GLUE Common Stock 17,310 23 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GLUE Stock Option (Right to Buy) 23 Jun 2021 Common Stock 51,931 $1.13 Direct F1
holding GLUE Stock Option (Right to Buy) 23 Jun 2021 Common Stock 182,353 $6.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option became vested and exercisable on May 1, 2021, with the remainder vesting in 36 substantially equal monthly installments thereafter.
F2 25% of this option shall vest and become exercisable on April 9, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney